Hydroxypropyl-Beta Cyclodextrin Barrier Prevents Respiratory Viral Infections
The emergence and mutation of pathogenic viruses have been occurring at an unprecedented rate in recent decades. The coronavirus disease
Tag: SBECD
Antiepileptic drug with betadex sulfobutyl ether sodium, Fycompa® injection approved in Japan
Eisai Co., Ltd. announced that they have obtained marketing authorization approval from the Japanese authorities for an injection formulation of
Zinc Diethyldithiocarbamate–Cyclodextrin Inclusion Complexes for Potential Lung Cancer Treatment
Zinc diethyldithiocarbamate (Zn (DDC)2), a disulfiram metabolite (anti-alcoholism drug), has shown a strong anti-cancer activity in vitro. However, its application
Renal safety of SBECD
Drug Development & Delivery published an interesting review on sulfobutyl ether beta-cyclodextrin (Captisol) in its October issue (2023). In addition
Enhancing solubility and stability of piperine using β-cyclodextrin derivatives: computational and experimental investigations
Piperine (PP), a natural alkaloid found in black pepper, possesses significant bioactivities (activation of the heat- and acidity-sensing transient receptor
Thymoquinone-Sulfobutylether-β-Cyclodextrin Inclusion Complex for Anticancer Applications
Thymoquinone (TQ) is a quinone derived from the black seed Nigella sativa and has been extensively studied in pharmaceutical and
Alpha-synuclein misfolding inhibitor minzasolmin dissolved in SBECD for treatment of Parkinson disease
Direct targeting of alpha-synuclein (ASYN) has emerged as a disease-modifying strategy for Parkinson’s disease and other synucleinopathies which is being
Ceftobiprole/SBECD complexes
This paper presents the theoretical calculations of the inclusion complex formation between native ceftobiprole, a promising antibiotic from the cephalosporin
Curcumin-sulfobutyl-ether beta-cyclodextrin inclusion complex: preparation, spectral characterization, molecular modeling, and antimicrobial activity
The present study aims to form a complex of curcumin (CUR) with Sulfobutyl ether-β-cyclodextrin (SBEβCD) to overcome the poor solubility
Enhanced Anti-Herpetic Activity of Valacyclovir Loaded in Sulfobutyl-ether-β-cyclodextrin-decorated Chitosan Nanodroplets
Valacyclovir (VACV) was developed as a prodrug of the most common anti-herpetic drug Acyclovir (ACV), aiming to enhance its bioavailability.